| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.083 | 0.4 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.095 | 0.4 |